Clinical Pharmacology and Therapeutics Flashcards
MOA flecainide
NAv1.5 sodium channel blocker
indications of flecainide
atrial fibrillation
SVT associated with accessory pathway e.g. Wolf-Parkinson-White syndrome
contraindications flecainide
post myocardial infarction
structural heart disease: e.g. heart failure
sinus node dysfunction; second-degree or greater AV block
atrial flutter
amiloride MOA
Na channel blocker in the Distal Convoluted Tubule.
Amiloride uses
- weak diuretic - given alongside other diuretics as it is a potassium sparing diuretic to prevent hypokalaemia
- given in Liddles syndrome- reduces increased sodium channel activity
aldosterone MOA
acts on the cortical collecting duct
what type of metabolic disturbance does cocaine cause
metabolic acidosis
what antibiotic to avoid in epileptics
ciprofloxacin
side effects of dopamine agonists
nausea/vomiting postural hypotension hallucinations daytime somnolence ergot derived-cabergoline, bromocript- retroperitoneal fibrosis
example of a depolarising muscle relaxant used in rapid sequence induction i a non fasted state
suxamethonium
side effects of sildenafil
visual disturbances e.g. blue discolouration, non-arteritic anterior ischaemic neuropathy nasal congestion flushing gastrointestinal side-effects headache
therapeutic drug monitoring mnemonic
have a Date @ 6, so i will be Late @ 12.
Call before you check and PHone if in doubt.
Drugs that cause impaired glucose intolerance
thiazides, steroids, Tacrolimus, Ciclosporin, Interferon-alpha, nicotinic acid, anti-psychotics
rituximab is a monoclonal antibody that acts on what marker
CD20
clinical features of ecstasy poisoning
neurological: agitation, anxiety, confusion, ataxia
cardiovascular: tachycardia, hypertension
hyponatraemia
hyperthermia
rhabdomyolysis